All genotype data were approved and provided by the National Biobank of Korea and the Centers for Disease Control and Prevention, the Republic of Korea (no. 2019-022). Genotyping in the Ansung–Ansan cohort study was performed using the Affymetrix genome-wide human SNP array 5.0, and genotype imputation was performed using IMPUTE2; the 1000 genome projects of the East Asian ancestry sample was used as a reference panel. Genotyping in the HEXA study was performed using the Korean Chip designed by the Center for Genome Science at the Korean National Institutes of Health. The expected genotyping and quality-control information has been described previously in detail29 (link),30 (link).
Free full text: Click here